Figures computed from official regulatory filings — methodology.
| Insider | Type | Value · USD | |
|---|---|---|---|
| KPCB XIV Associates, LLC | Other | $213.3M | SEC |
| VAN VLASSELAER PETER | OtherD | $9.3M | SEC |
| VAN VLASSELAER PETER | Other | $40.5M | SEC |
| Xu Stella | OtherD | $180.5K | SEC |
| SEIDENBERG BETH C | OtherD | $180.5K | SEC |
| Rizvi Naiyer | OtherD | $828.4K | SEC |
| Xu Stella | Other | $20.2M | SEC |
| Rizvi Naiyer | OtherD | $180.5K | SEC |
| VAN VLASSELAER PETER | OtherD | $10.7M | SEC |
| GORDON CARL L | Other | $20.5M | SEC |
| VAN VLASSELAER PETER | OtherD | $18.6M | SEC |
| CROSS HERB | OtherD | $10.4M | SEC |
| Cui Xiangmin | Other | $60.7M | SEC |
| GORDON CARL L | Other | $185.5M | SEC |
| VAN VLASSELAER PETER | OtherD | $9.3M | SEC |
| Legault Pierre | OtherD | $180.5K | SEC |
| SEIDENBERG BETH C | Other | $213.3M | SEC |
| OrbiMed Capital GP IV LLC | Other | $185.5M | SEC |
| Cui Xiangmin | OtherD | $180.5K | SEC |
| OrbiMed Capital GP IV LLC | Other | $20.5M | SEC |
| GORDON CARL L | OtherD | $180.5K | SEC |
| Legault Pierre | OtherD | $2.4M | SEC |
| Leveque Joseph | OtherD | $12.4M | SEC |
| GORDON CARL L | AwardD | $0 | SEC |
| SEIDENBERG BETH C | AwardD | $0 | SEC |